Active Ingredient: Ciprofloxacin
Small orders accepted. Have you taken a quinolone antibiotic e.
The powerful placebo effect: fact or fiction? J Clin Epidemiol. Clin Infect Dis. Intramuscular antibiotics in the treatment of pediatric upper respiratory tract infections.
Am J Manag Care.
Guidelines for the use of antibiotics in acute upper respiratory tract infections. Am Fam Physician. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Pohl A.
Cochrane Database Syst Rev.
The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med. Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
The AAP practice parameter on urinary tract infections in febrile infants and young children. In an era defined by antimicrobial resistance AMR and an increasing drive toward delivering patient care via ambulatory pathways, the paradigm for the management of infections is changing.
This article reviews the spectrum of antimicrobial agents currently available for the treatment of Gram-positive infections with a special focus on AMR, and outpatient antimicrobial therapy OPAT.
Also reviewed are agents currently in development, and renaissance roles for older antimicrobials in cases complicated by AMR. It is resistant to many commonly prescribed antibiotics.
However, in vulnerable people, such as those that have recently had surgery, it can cause wound infections, pneumonia and blood poisoning. The prevalence of drug-resistant strains of Gram-positive bacteria including methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococci is increasing.
An increasing proportion of specialist infection care is being delivered in ambulatory settings, including outpatient antimicrobial therapy OPAT.
A number of new antimicrobials with activity against drug-resistant Gram-positive organisms have been licensed recently; a number of these are novel examples of existing classes.
A number of existing antimicrobials have important activity against drug-resistant Gram-positive organisms. Such agents are likely to become increasingly useful, particularly in cases where oral therapy is appropriate.